Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-25 @ 2:21 AM
NCT ID:
NCT05254834
Eligibility Criteria:
Key Inclusion Criteria:
* Age at least 30 years
* Able and willing to provide blood samples per protocol
* Able to comprehend and willing to sign and date the informed consent documents
* Participants must meet one of the following:
* Diagnosed with a single primary cancer that has not yet been treated
* No evidence or treatment of any cancer for at least 5 years prior to enrollment
Key Exclusion Criteria:
* A medical condition which, in the opinion of the investigator, should preclude enrollment in the study
* Known to be pregnant
* Any therapy for cancer, including surgery, chemotherapy, immunotherapy, and/or radiation therapy in the 5 years preceding enrollment
* Participated or currently participating in a clinical research study in which an experimental medication has been administered in the last 30 days
* Participated in or currently participating in another Freenome clinical study
* For the control cohort: Any previous cancer diagnosis in the 5 years preceding enrollment, or recurrence of the same primary cancer within any timeframe; or concurrent diagnosis of multiple primary cancers within any timeframe
* For the cancer cohorts: Any previous cancer diagnosis in the 5 years preceding enrollment, apart from the current cancer diagnosis; OR recurrence of the same primary cancer within any timeframe; OR concurrent diagnosis of multiple primary cancers within any timeframe
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT05254834
Study Brief:
Protocol Section:
NCT05254834